PubMed چکیده/رکورد

Preoperative Contralateral Joint And/Or Back Pain Impact on Achieving the Substantial Clinical Benefit for Hip Disability and Osteoarthritis Outcome Score-Joint Replacement.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: The Centers for Medicare & Medicaid Services recently mandated reporting of patient-reported outcome measures following primary total hip arthroplasty (THA), with emphasis on the substantial clinical benefit (SCB) threshold for the Hip Disability and Osteoarthritis Outcome Score-Joint Replacement (HOOS-JR). The impact of preoperative back and/or contralateral hip pain on achieving SCB and other validated patient-reported outcome measure thresholds remains unclear. METHODS: We retrospectively analyzed a prospective cohort of 4,412 Medicare primary elective unilateral THAs (2016 to 2023). Patients were stratified by preoperative back and/or contralateral hip pain and severity. Outcomes included achievement of SCB (22-point improvement in HOOS-JR), minimal clinically important difference, patient-acceptable symptom state, and satisfaction at one year. Multivariable logistic regression was adjusted for demographic, clinical, and socioeconomic factors. RESULTS: Patients who had both back and contralateral hip pain had the highest odds of failing to achieve SCB (odds ratio (OR) 3.1, 95% confidence interval (CI) 2.4 to 4.1; P < 0.001), followed by isolated contralateral hip pain (OR 1.7, 95% CI 1.1 to 2.6; P = 0.01) and isolated back pain (OR 1.6, 95% CI 1.2 to 2.0; P = 0.002). Risk increased proportionally with pain severity (mild/moderate back pain: OR 1.7; severe back pain: OR 2.8; both P < 0.001). Similar, though less pronounced, patterns were observed for minimal clinically important difference and patient-acceptable symptom state thresholds across HOOS domains. Patients who have both pain sources also reported the highest risk of dissatisfaction (OR 2.1, 95% CI 1.5 to 3.0; P < 0.001). CONCLUSIONS: Preoperative back and contralateral hip pain, particularly when severe or concurrent, strongly and independently reduce the likelihood of achieving SCB for HOOS-JR following primary THA. These findings underscore the need for risk adjustment under the Centers for Medicare & Medicaid Services patient-reported outcome performance measure framework and highlight the value of multidisciplinary management of comorbid pain to optimize outcomes and ensure equitable benchmarking in value-based care. LEVEL OF EVIDENCE: II (Prospective).

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

Hip Disability and Osteoarthritis Outcome Score–Joint Replacementcontralateral hip painlow back painsubstantial clinical benefittotal hip arthroplasty
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

AA in Rheumatoid Arthritis and Lupus.

Inflammation and immune dysregulation are at the center of various diseases, including autoimmune diseases, especially rheumatoid arthritis (RA) and systemic lupus erythematosus (lupus). In general, corticosteroids, disease-modifying drugs, and monoclonal antibodies against IL-6 and TNF-α, JAK inhibitors, and various other immunomodulators are extensively used in the treatment of RA and lupus. It is known that EFA (essential fatty acid…

PubMed2026

A Notch signaling antagonist (DAPT) ameliorates autoimmune arthritis in mice by suppressing Th1 and Th17 immune responses.

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease for which targeted therapies remain limited. The Notch signaling pathway has been implicated in T cell differentiation and autoimmune inflammation. OBJECTIVES: This study aimed to investigate the therapeutic effects of the Notch signaling antagonist DAPT on autoimmune arthritis in mice and to explore its underlying immunological mechanisms. METHODS: A co…

PubMed2026

Corrigendum to: Bone marrow mesenchymal stem cells relieve rheumatoid arthritis by blocking JAK/STAT and TLR-4/NF-?B pathways.

The authors have informed the Pakistan Journal of Pharmaceutical Sciences (PJPS) of an error in Figure 5 of the published article. During the editorial revision process, an incorrect version of Figure 5 was inadvertently included in the final published version. The authors have confirmed that the extreme-right panel (panel D) should be removed and that the remaining panels constitute the corrected Figure 5. Accordingly, Figure 5 is cor…

PubMed2026

Culturally Embedded Participation Restrictions in Indian Adults With Knee Osteoarthritis: An ICF-Based Qualitative Study.

OBJECTIVE: To identify culturally relevant functioning issues experienced by Indian adults with knee osteoarthritis (KOA) using the International Classification of Functioning, Disability and Health (ICF) framework. METHODS: A qualitative descriptive study using semi-structured focus group interviews was conducted with 38 ambulatory adults (35-85 years) diagnosed with knee osteoarthritis (KOA). Participants were recruited from physioth…